AJP - Endocrinology and Metabolism, Vol 260, Issue 5 E705-E712, Copyright © 1991 by American Physiological Society

ARTICLES

Catecholamines in prevention of hypoglycemia during exercise in humans

J. C. Marker, I. B. Hirsch, L. J. Smith, C. A. Parvin, J. O. Holloszy and P. E. Cryer
Division of Endocrinology, Diabetes, and Metabolism, Washington University School of Medicine, St. Louis, Missouri 63110.

To assess the role of catecholamines in the prevention of hypoglycemia during moderate exercise (approximately 60% peak O2 consumption for 60 min), normal humans were studied with combined alpha- and beta-adrenergic blockade and with adrenergic blockade while changes in insulin and glucagon were prevented with the islet clamp technique (somatostatin infusion with insulin and glucagon infused at fixed rates). The results were compared with those from an islet clamp alone study. In contrast to a comparison study (saline infusion), adrenergic blockade resulted in a small initial decrease in plasma glucose during exercise, from 5.0 +/- 0.2 to 4.4 +/- 0.2 mmol/l (P less than 0.01), but the level then plateaued. There was a substantial exercise-associated decrement in plasma glucose when insulin and glucagon were held constant, i.e., from 5.5 +/- 0.2 to 3.4 +/- 0.2 mmol/l (P less than 0.0001), but the level again plateaued. However, when insulin and glucagon were held constant and catecholamine actions were blocked simultaneously, progressive hypoglycemia, to 2.6 +/- 0.6 mmol/l (P less than 0.001), developed during exercise. Hypoglycemia was the result of an absent increase in glucose production and an exaggerated initial increase in glucose utilization. Thus we conclude that sympathochromaffin activation plays a minor role when insulin and glucagon are operative, but a catecholamine, probably epinephrine, becomes critical to the prevention of hypoglycemia during exercise when changes in insulin and glucagon do not occur.

This article has been cited by other articles:

				T. J. Horton, G. K. Grunwald, J. Lavely, and W. T. Donahoo Glucose kinetics differ between women and men, during and after exercise J Appl Physiol, June 1, 2006; 100(6): 1883 - 1894. [Abstract] [Full Text] [PDF]

				J. A. Kanaley, R. Dall, N. Moller, S. C. Nielsen, J. S. Christiansen, M. D. Jensen, and J. O. L. Jorgensen Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men J Appl Physiol, February 1, 2004; 96(2): 747 - 753. [Abstract] [Full Text] [PDF]

				D. G. Hunt, Z. Ding, and J. L. Ivy Propranolol prevents epinephrine from limiting insulin-stimulated muscle glucose uptake during contraction J Appl Physiol, August 1, 2002; 93(2): 697 - 704. [Abstract] [Full Text] [PDF]

				R. H. Coker, Y. Koyama, J. C. Denny, R. C. Camacho, D. B. Lacy, and D. H. Wasserman Prevention of Overt Hypoglycemia During Exercise: Stimulation of Endogenous Glucose Production Independent of Hepatic Catecholamine Action and Changes in Pancreatic Hormone Concentration Diabetes, May 1, 2002; 51(5): 1310 - 1318. [Abstract] [Full Text] [PDF]

				J. S. Greiwe, J. O. Holloszy, and C. F. Semenkovich Exercise induces lipoprotein lipase and GLUT-4 protein in muscle independent of adrenergic-receptor signaling J Appl Physiol, July 1, 2000; 89(1): 176 - 181. [Abstract] [Full Text] [PDF]

				B. Burguera, D. Proctor, N. Dietz, Z. Guo, M. Joyner, and M. D. Jensen Leg free fatty acid kinetics during exercise in men and women Am J Physiol Endocrinol Metab, January 1, 2000; 278(1): E113 - E117. [Abstract] [Full Text] [PDF]

				K. Howlett, M. Febbraio, and M. Hargreaves Glucose production during strenuous exercise in humans: role of epinephrine Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1130 - E1135. [Abstract] [Full Text] [PDF]

				P. Del Corral, E. T. Howley, M. Hartsell, M. Ashraf, and M. S. Younger Metabolic effects of low cortisol during exercise in humans J Appl Physiol, March 1, 1998; 84(3): 939 - 947. [Abstract] [Full Text] [PDF]